
Accomplished biotechnology executive with over twenty years of expertise, specializing in the strategic advancement of innovative therapeutics in the dynamic hematology-oncology sector.
· Responsible for oversight, management and drive across the entire span of development from strategy formulation to execution of that strategy; this encompassed the entire process from preclinical research through product launch.
· Accountable for high level oversight and management of all key program deliverables including program strategy, regulatory submissions, drug supply and manufacturing, clinical trial execution,publication platform, communications strategy, MSL engagement plan, congress planning, patient advocacy and other activities.
· Continually assessed program performance, scientific data, development feasibility, regulatory precedent and competitive intelligence to evaluate strategic fit with overall corporate portfolio; presented program insights and recommendations to Board of Directors and Executive Leadership Team on routine basis.
· Led program team of functional experts to ensure consistent communication and alignment, operational efficiency and program success.